Novavax Inc (NVAX) — Cash Flow Reinvestment Rate

Latest as of September 2025: 1.29x

Novavax Inc (NVAX) has a Cash Flow Reinvestment Rate of 1.29x as of September 2025, reinvesting $138.55 Million (capex $2.02 Million plus investments $-136.53 Million) from operating cash flow of $107.80 Million. See NVAX FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

1.29x
(Capex + Investments) / Operating CF

Total Reinvested

$138.55 Million
Capex + Investments

Operating Cash Flow

$107.80 Million
USD

Capital Expenditures

$2.02 Million
USD

Novavax Inc Cash Flow Reinvestment Rate (2021–2021)

Historical reinvestment intensity for Novavax Inc across 1 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Novavax Inc.

Annual Cash Flow Reinvestment Rate for Novavax Inc (2021–2021)

Year-by-year capital reinvestment analysis for Novavax Inc. See Novavax Inc leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2021 0.67x $215.13 Million $322.95 Million $57.49 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow